• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码 RNA 在糖尿病肾病中的作用:发病机制、生物标志物和治疗策略。

Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.

机构信息

Diabetes Research Center, Medical School of Ningbo University, Ningbo, 315000 Zhejiang, China.

The Affiliated Hospital of Medical School of Ningbo University, Ningbo, 315000 Zhejiang, China.

出版信息

J Diabetes Res. 2020 Jun 19;2020:3960857. doi: 10.1155/2020/3960857. eCollection 2020.

DOI:10.1155/2020/3960857
PMID:32656264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7327582/
Abstract

The correlation between diabetes and systematic well-being on human life has long established. As a common complication of diabetes, the prevalence of diabetic nephropathy (DN) has been increasing globally. DN is known to be a major cause of end-stage kidney disease (ESKD). Till now, the molecular mechanisms for DN have not been fully explored and the effective therapies are still lacking. Noncoding RNAs are a class of RNAs produced by genome transcription that cannot be translated into proteins. It has been documented that ncRNAs participate in the pathogenesis of DN by regulating inflammation, apoptosis, autophagy, cell proliferation, and other pathological processes. In this review, the pathological roles and diagnostic and therapeutic potential of three types of ncRNAs (microRNA, long noncoding RNA, and circular RNA) in the progression of DN are summarized and illustrated.

摘要

糖尿病与人类系统健康之间的相关性早已确立。作为糖尿病的常见并发症,糖尿病肾病(DN)的患病率在全球范围内不断上升。DN 是导致终末期肾病(ESKD)的主要原因。到目前为止,DN 的分子机制尚未被充分探索,有效的治疗方法仍然缺乏。非编码 RNA 是一类由基因组转录产生的不能翻译成蛋白质的 RNA。有文献记载,ncRNA 通过调节炎症、细胞凋亡、自噬、细胞增殖等病理过程参与 DN 的发病机制。本综述总结并说明了三种 ncRNA(microRNA、长链非编码 RNA 和环状 RNA)在 DN 进展中的病理作用及诊断和治疗潜力。

相似文献

1
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.非编码 RNA 在糖尿病肾病中的作用:发病机制、生物标志物和治疗策略。
J Diabetes Res. 2020 Jun 19;2020:3960857. doi: 10.1155/2020/3960857. eCollection 2020.
2
Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.环状 RNA;克服糖尿病肾病的强大 microRNA 海绵。
Pathol Res Pract. 2021 Nov;227:153618. doi: 10.1016/j.prp.2021.153618. Epub 2021 Sep 15.
3
Epigenetic Regulations in Diabetic Nephropathy.糖尿病肾病中的表观遗传调控
J Diabetes Res. 2017;2017:7805058. doi: 10.1155/2017/7805058. Epub 2017 Mar 19.
4
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.长链非编码RNA-Gm4419敲低可改善糖尿病肾病中核因子κB/核苷酸结合寡聚化结构域样受体蛋白3炎性小体介导的炎症反应。
Cell Death Dis. 2017 Feb 2;8(2):e2583. doi: 10.1038/cddis.2016.451.
5
Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.糖尿病肾病中长链非编码RNA表达模式的微阵列分析
J Diabetes Complications. 2017 Mar;31(3):569-576. doi: 10.1016/j.jdiacomp.2016.11.017. Epub 2016 Dec 8.
6
MicroRNA: A new generation therapeutic target in diabetic nephropathy.微小 RNA:糖尿病肾病治疗的新一代靶点。
Biochem Pharmacol. 2018 Sep;155:32-47. doi: 10.1016/j.bcp.2018.06.017. Epub 2018 Jun 22.
7
The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.非编码 RNA 在糖尿病肾病中的作用:作为疾病发展和进展的生物标志物的潜在应用。
Diabetes Res Clin Pract. 2013 Jan;99(1):1-11. doi: 10.1016/j.diabres.2012.10.010. Epub 2012 Oct 25.
8
The role of ncRNAs-mediated pyroptosis in diabetes and its vascular complications.ncRNAs 介导的细胞焦亡在糖尿病及其血管并发症中的作用。
Cell Biochem Funct. 2024 Mar;42(2):e3968. doi: 10.1002/cbf.3968.
9
Non-Coding RNA and Diabetic Kidney Disease.非编码RNA与糖尿病肾病
DNA Cell Biol. 2021 Apr;40(4):553-567. doi: 10.1089/dna.2020.5973. Epub 2021 Mar 17.
10
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.糖尿病肾病中的微小RNA:功能、生物标志物及治疗靶点
Ann N Y Acad Sci. 2015 Sep;1353(1):72-88. doi: 10.1111/nyas.12758. Epub 2015 Apr 15.

引用本文的文献

1
Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs.长链非编码RNA和环状RNA对糖尿病肾病中细胞焦亡的调控
Clin Exp Med. 2025 Jun 18;25(1):208. doi: 10.1007/s10238-025-01740-w.
2
The application value of multimodal ultrasound imaging technology in the prediction of early-stage type 2 diabetic kidney disease.多模态超声成像技术在早期2型糖尿病肾病预测中的应用价值
Sci Rep. 2025 Apr 11;15(1):12520. doi: 10.1038/s41598-025-97151-8.
3
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.

本文引用的文献

1
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression.血液和脑脊液中的微小RNA作为多发性硬化症的诊断生物标志物及用于监测疾病进展。
Neural Regen Res. 2020 Apr;15(4):606-619. doi: 10.4103/1673-5374.266905.
2
Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin.同时评估糖尿病肾病患者的 microRNAs 126 和 192 及其与尿白蛋白的关系。
Curr Mol Med. 2020;20(5):361-371. doi: 10.2174/1566524019666191019103918.
3
Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway.
糖尿病肾病的发病机制、生物标志物及治疗方法:当前见解与未来展望
J Clin Med. 2025 Jan 23;14(3):727. doi: 10.3390/jcm14030727.
4
Long noncoding RNA Gm4419 promotes mesangial cell proliferation and extracellular matrix accumulation the miR-455-3p/histone deacetylase 2 axis.长链非编码RNA Gm4419通过miR-455-3p/组蛋白去乙酰化酶2轴促进系膜细胞增殖和细胞外基质积聚。
Heliyon. 2024 Oct 2;11(1):e38835. doi: 10.1016/j.heliyon.2024.e38835. eCollection 2025 Jan 15.
5
Research progress of non-coding RNA regulating the role of PANoptosis in diabetes mellitus and its complications.非编码RNA调控PAN细胞焦亡在糖尿病及其并发症中作用的研究进展
Apoptosis. 2025 Apr;30(3-4):516-536. doi: 10.1007/s10495-024-02066-w. Epub 2025 Jan 4.
6
Novel Insights into Diabetic Kidney Disease.糖尿病肾病的新见解。
Int J Mol Sci. 2024 Sep 23;25(18):10222. doi: 10.3390/ijms251810222.
7
Research progress on in the treatment of diabetic nephropathy.糖尿病肾病治疗的研究进展。 需注意,你提供的原文“Research progress on in the treatment of diabetic nephropathy.”中“on”后面似乎少了具体内容。
Front Pharmacol. 2024 Jun 14;15:1390672. doi: 10.3389/fphar.2024.1390672. eCollection 2024.
8
Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy.了解非编码RNA和外泌体非编码RNA在糖尿病肾病中的作用。
Curr Mol Med. 2024 Apr 5. doi: 10.2174/0115665240287631240321072504.
9
The implication of miR-200a and miR-132 expression and their correlations with NF-κB/TNF-alpha signaling in adults with diabetic nephropathy.miR-200a和miR-132表达的意义及其与成年糖尿病肾病患者中NF-κB/TNF-α信号传导的相关性。
Saudi J Biol Sci. 2024 May;31(5):103975. doi: 10.1016/j.sjbs.2024.103975. Epub 2024 Mar 16.
10
Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.尿外泌体微小RNA-145-5p和微小RNA-27a-3p作为糖尿病肾病的非侵入性诊断生物标志物。
World J Diabetes. 2024 Jan 15;15(1):92-104. doi: 10.4239/wjd.v15.i1.92.
黄芪甲苷IV通过调节TGF-β1/Smad/miR-192信号通路抑制糖尿病肾病引起的系膜细胞过度增殖和肾纤维化。
Exp Ther Med. 2019 Oct;18(4):3053-3061. doi: 10.3892/etm.2019.7887. Epub 2019 Aug 14.
4
miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.miR-218 通过靶向 IKK-β 并调节 NK-κB 介导的炎症来调控糖尿病肾病。
J Cell Physiol. 2020 Apr;235(4):3362-3371. doi: 10.1002/jcp.29224. Epub 2019 Sep 24.
5
Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.长链非编码 RNA XIST 的沉默通过 microRNA-93-5p 介导的 CDKN1A 抑制防止糖尿病肾病肾间质纤维化。
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1350-F1358. doi: 10.1152/ajprenal.00254.2019. Epub 2019 Sep 23.
6
LINC00462 is involved in high glucose-induced apoptosis of renal tubular epithelial cells via AKT pathway.长链非编码RNA 00462通过AKT信号通路参与高糖诱导的肾小管上皮细胞凋亡。
Cell Biol Int. 2020 Jan;44(1):286-294. doi: 10.1002/cbin.11231. Epub 2019 Sep 23.
7
MicroRNA‑379‑5p suppresses renal fibrosis by regulating the LIN28/let‑7 axis in diabetic nephropathy.微小 RNA-379-5p 通过调节 LIN28/let-7 轴抑制糖尿病肾病中的肾纤维化。
Int J Mol Med. 2019 Nov;44(5):1619-1628. doi: 10.3892/ijmm.2019.4325. Epub 2019 Aug 30.
8
Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.卡托普利和螺内酯通过靶向 microRNA-192 和 microRNA-29a/b/c 可减轻 Wistar 大鼠糖尿病肾病。
DNA Cell Biol. 2019 Oct;38(10):1134-1142. doi: 10.1089/dna.2019.4732. Epub 2019 Aug 21.
9
Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling.齐墩果酸通过miRNA-142-5p/PTEN信号通路激活自噬减轻糖尿病肾小球系膜细胞损伤。
Cytotechnology. 2019 Oct;71(5):925-933. doi: 10.1007/s10616-019-00335-0. Epub 2019 Aug 13.
10
Caffeic Acid Modulates miR-636 Expression in Diabetic Nephropathy Rats.咖啡酸调节糖尿病肾病大鼠中miR-636的表达。
Indian J Clin Biochem. 2019 Jul;34(3):296-303. doi: 10.1007/s12291-018-0743-0. Epub 2018 Feb 26.